NASDAQ · Medical - Instruments & Supplies

BLFS (BLFS) Stock

$35.47 -4.32% NASDAQ: BLFS Healthcare

Valuation

MetricValue
Price$35.47
Market Cap$1.73B
P/E Ratio-96.00
P/B Ratio3.15
P/S Ratio11.76
EPS (TTM)$0.00
52-Week High$37.98
52-Week Low$17.86
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-3.23%
ROA-2.96%
ROCE-3.23%
Gross Margin-12.50%
Operating Margin-12.50%
Net Margin-10.52%
Debt/Equity0.04
Current Ratio5.96

Annual Financials (USD)

Metric20212022202320242025
Revenue$119.0M$76.0M$76.0M$82.0M$96.0M
Operating Profit$-35.0M$-6.0M$-23.0M$-7.0M$-12.0M
Net Profit$-9.0M$-140.0M$-66.0M$-20.0M$-12.0M
EPS$-0.23$-3.29$-1.52$-0.44$-0.25
Op Margin-29.5%-7.8%-30.9%-8.7%-12.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$553.0M$450.0M$413.0M$399.0M$406.0M
Total Liabilities$76.0M$86.0M$75.0M$51.0M$34.0M
Cash$70.0M$19.0M$28.0M$95.0M$33.0M
Borrowings$27.0M$44.0M$34.0M$30.0M$18.0M

Latest News

BLFS: Raising target price to $30.00 Argus Research · Jul 15, 2026 What Makes BioLife Solutions (BLFS) a Compelling Long-Term Hold? Insider Monkey · Jun 18, 2026 BioLife Solutions Leads 3 Stocks Estimated To Be Trading Below Fair Value Simply Wall St. · Jun 4, 2026 Orthofix Medical and 5 More Stocks See Action From Activist Investors Barrons.com · May 29, 2026 A Look At BioLife Solutions (BLFS) Valuation As Shares Show Recent Short Term Momentum Simply Wall St. · May 11, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-5.0M$-8.0M$-12.0M$8.0M$20.0M
Investing Cash Flow$-21.0M$-69.0M$11.0M$55.0M$-81.0M
Financing Cash Flow$-1.0M$-2.0M$1.0M$0$-1.0M
Net Cash Flow$-21.0M$-50.0M$16.0M$60.0M$-62.0M
Free Cash Flow$-13.0M$-19.0M$-19.0M$5.0M$11.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-0.15%
Quick Ratio5.50
Interest Coverage-4.00
Return 1Y37.06%
Return 3Y57.47%
Return 5Y-34.21%

Ownership

Insiders Held2.37%
Institutions Held104.50%
Institutions Float Held107.03%
Institutional HolderSharesReport Date
T. Rowe Price Investment Management, Inc.6,506,3462026-03-31
Blackrock Inc.6,101,7652026-03-31
Casdin Capital, LLC5,957,1652026-03-31
Invesco Ltd.2,348,5322026-03-31
Vanguard Capital Management LLC1,917,7082026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ATRC $48.92 +1.18% 80.24 $2.49B 0.00%
AZTA $31.57 -3.31% -15.22 $1.46B 0.00%
ESTA $69.55 +0.32% -38.58 $2.05B 0.00%
HROW $36.97 +0.16% 14.50 $1.38B 0.00%
KMTS $25.12 -2.45% -3.85 $1.47B 0.00%

About BLFS

BLFS is led by CEO Roderick de Greef, employs 159 people, headquartered in US, publicly traded since 1989.

BLFS stock trades at $35.47 with a market capitalization of $1.73B. The stock is valued at a price-to-earnings (P/E) ratio of -96.00, price-to-book of 3.15, price-to-sales of 11.76. Over the past 52 weeks the stock has ranged between $17.86 and $37.98, and currently trades 6.6% below its 52-week high.

On profitability, BLFS generates a return on equity (ROE) of -3.23%, return on capital employed of -3.23%, an operating margin of -12.50%, a net profit margin of -10.52%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides